Effect of ramipril on the incidence of diabetes.

Effect of ramipril on the incidence of diabetes.

BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...

Bibliografske podrobnosti
Main Authors:	Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R
Format:	Journal article
Jezik:	English
Izdano:	2006

Podobne knjige/članki

Incidence of diabetes following ramipril or rosiglitazone withdrawal
od: Holman, R, et al.
Izdano: (2011)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
od: Investigators, D
Izdano: (2011)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
od: Punthakee, Z, et al.
Izdano: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
od: Gerstein, H, et al.
Izdano: (2006)

Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
od: G. Gulli
Izdano: (2013-05-01)

Ramipril induced pemphigoid vulgaris
od: Mirza MA, et al.
Izdano: (2018-09-01)

Ramipril therapy in acute myocardial infarction
od: V. A. Lusov, et al.
Izdano: (2008-10-01)

Ramipril poisoning rescued by naloxone and terlipressin
od: Samanta Samanta, et al.
Izdano: (2014-01-01)

The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic
od: Katarzyna Regulska, et al.
Izdano: (2023-02-01)

Effect of ramipril on renal function in patients with intermittent claudication
od: Simon D Hobbs, et al.
Izdano: (2008-04-01)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
od: Hertzel C. Gerstein, et al.
Izdano: (2022-08-01)

V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii
od: I E Chazova, et al.
Izdano: (2011-09-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
od: I. V. Szirov, et al.
Izdano: (2015-12-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
od: S. V. Nedogoda
Izdano: (2016-09-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
od: Kateryna Typlynska, et al.
Izdano: (2023-04-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
od: I. V. Szirov, et al.
Izdano: (2015-12-01)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Izdano: (2008)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
od: E. E. Averin, et al.
Izdano: (2019-01-01)

Effect of Valsartan on the Incidence of Diabetes REPLY
od: Holman, R, et al.
Izdano: (2010)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
od: S. R. Willoughby, et al.
Izdano: (2015-12-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
od: S. R. Willoughby, et al.
Izdano: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
od: B J C Onwubere, et al.
Izdano: (2007-01-01)

MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
od: Paul Valensi MD, et al.
Izdano: (2024-06-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
od: O. A. Terenteva, et al.
Izdano: (2021-12-01)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
od: I. E. Chazova, et al.
Izdano: (2010-08-01)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
od: McMurray, J, et al.
Izdano: (2014)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
od: V. I. Podzolkov, et al.
Izdano: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
od: V. I. Podzolkov, et al.
Izdano: (2015-09-01)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
od: M. Dalla Vestra, et al.
Izdano: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
od: A. I. Chesnikova, et al.
Izdano: (2016-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
od: Katarzyna Regulska, et al.
Izdano: (2021-10-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
od: M.A. Dolinnayä, et al.
Izdano: (2017-03-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
od: A. G. Kuzmin, et al.
Izdano: (2014-08-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
od: M. V. Leonova
Izdano: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
od: D. A. Napalkov, et al.
Izdano: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
od: A. A. Shadrin, et al.
Izdano: (2019-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
od: Duygun Altıntaş Aykan, et al.
Izdano: (2020-10-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
od: D. A. Napalkov, et al.
Izdano: (2016-01-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
od: A. O. Konradi, et al.
Izdano: (2020-04-01)

Development and validation of a stability indicating UPLC-DAD method coupled with MS-TQD for ramipril and thymoquinone in bioactive SNEDDS with in silico toxicity analysis of ramipril degradation products
od: Elzayat Ehab M., et al.
Izdano: (2024-08-01)